Skip to content

The effect of interval training with different intensities on weight loss and brown adipose tissue markers

The effect of 12 weeks of interval training with different intensity on serum levels of Fibroblast growth factor 21, Myostatin and Irisin in obese and overweight men

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT20190719044269N1
Enrollment
50
Registered
2020-03-30
Start date
2019-09-28
Completion date
Unknown
Last updated
2020-04-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Obesity and overweight. Overweight and obesity

Interventions

Intervention 1: Intervention group: heavy interval training, Three times a week, 12 weeks, with an intensity of 88-93% of maximum heart rate, Duration of activity from the beginning to the end of the

Sponsors

The University of Tehran
Lead Sponsor

Eligibility

Sex/Gender
Male
Age
20 Years to 25 Years

Inclusion criteria

Inclusion criteria: Young men (20,25) years Having a body mass index greater than 25 kg,m 2

Exclusion criteria

Exclusion criteria: Use of medication Tobacco use Having Chronic diseases Having Regular physical activity

Design outcomes

Primary

MeasureTime frame
Fibroblast growth factor 21(FGF21). Timepoint: First and 12 weeks later. Method of measurement: ELISA laboratory method.;Myostatin. Timepoint: First and 12 weeks later. Method of measurement: ELISA laboratory method.;Irisin. Timepoint: First and 12 weeks later. Method of measurement: ELISA laboratory method.

Secondary

MeasureTime frame
Body fat percentage. Timepoint: First and 12 weeks later. Method of measurement: Caliper.;Waist–hip ratio (WHR). Timepoint: First and 12 weeks later. Method of measurement: meters.;Body Mass Index. Timepoint: First and 12 weeks later. Method of measurement: Digital scales and meters.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactSaeed Ramezani

The University of Tehran

rsaeid92@gmail.com+98 58 3232 3963

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026